Breaks Categories: News

TuesdayFeb 13, 2024 8:30 am

NetworkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Engages Global CRO to Support NDA Submission for Approval of Tonmya(TM) for Fibromyalgia Management

Tonix Pharmaceuticals Holding (NASDAQ: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, has engaged Rho, Inc., a global contract research organization (“CRO”). Under the terms of the engagement, Rho will support Tonix in preparing its New Drug Application (“NDA”) for planned submission to the U.S. Food and Drug Administration (“FDA”) for the clearance of Tonmya(TM), a patented sublingual tablet formulation of cyclobenzaprine hydrochloride, for the management of fibromyalgia. “We are excited by our most recent positive Phase 3 study results of Tonmya and look forward to Rho’s support in preparing our NDA,” said Seth Lederman,…

Continue Reading

MondayFeb 12, 2024 1:50 pm

NetworkNewsBreaks — SenesTech Inc. (NASDAQ: SNES) Makes ‘First Major Move’ into Retail Market

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, has been accepted as a vendor for all Ace Hardware stores, which form a network comprising over 4,500 locations. According to the announcement, all Ace Hardware stores will be able to order directly from SenesTech, and the company will participate in Ace Hardware’s vendor events, including the Ace semi-yearly markets. “We are excited to be working with Ace Hardware. They represent leaders in the retail market for do-it-yourselfers and the consumer market, for which our Evolve(TM) soft bait is uniquely positioned,” said SenesTech’s President and CEO Joel…

Continue Reading

MondayFeb 12, 2024 1:42 pm

NetworkNewsBreaks – Bravo Multinational, Inc. (BRVO) Solidifies Entry into Dynamic World of Streaming

Bravo (OTC: BRVO) recently announced it has entered into an agreement to acquire the assets of Streaming TVEE, Inc., which stands at the forefront of licensed streaming technology. The agreement, the announcement states, solidifies Bravo’s entry into streaming and establishes the business foundation for its previously announced flagship offering, TVee NOW(TM), a new streaming service slated for Beta launch in Q1 2024. TVee NOW(TM) will be available directly to consumers via the web on any connected TV (“CTV”), smartphone or tablet and intends to offer traditional broadcast TV, which encompasses cable and satellite networks through a joint venture with Pythia…

Continue Reading

MondayFeb 12, 2024 1:31 pm

NetworkNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Reinforces Position as Market Leader with Announcement of New EM Contract in California

SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-government, Internet of Things (“IoT”) and cybersecurity sectors, has secured a new contract with an established California services provider in the judicial sector. According to the announcement, the contract is already operational and generating revenue; it also has long-term growth potential. SuperCom was awarded the contract over a long-time incumbent competitor, a reflection of the potential for the company’s new PureOne solution as well as its vision of expanding its footprint in the U.S. market and the competitive edge provided by delivering superior technology solutions. “We are pleased to announce a…

Continue Reading

MondayFeb 12, 2024 11:45 am

NetworkNewsBreaks — Upstream Offers Solutions to Hurdles for International Investors, Launches Exchange Dual Listing Program

Upstream, the revolutionary retail trading app for stocks and NFTs powered by Horizon Fintex and MERJ Exchange Limited, is working to create economic development for foreign exchanges and their issuers. As part of that focus, the company has announced its Exchange Dual Listing Program for 2024. “As it stands today, it is difficult for international investors to buy U.S.- and Canadian-listed securities,” a recent Upstream article stated. “Retail investors outside the U.S. and Canada don’t typically have streamlined access to purchase NASDAQ, NYSE, OTC, TSX, TSX.V, CSE or shares from smaller exchanges around the world without going through a cumbersome…

Continue Reading

MondayFeb 12, 2024 10:57 am

NetworkNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Closes on Nonbrokered Private Placement

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a Canadian-based, growth-stage company committed to providing commercially viable and sustainable, cradle-to-cradle, clean-energy solutions, has closed on the final tranche of its nonbrokered private placement. As part of the transaction, the company issued 9,961,909 units at $0.055 per unit, with a unit comprising one common share and one common share purchase warrant; the warrant allows holders to purchase an additional common share at $0.07 until Feb. 9, 2029. Gross proceeds for the placement totaled $547,905. “When combined with the first tranche of the offering, the company has raised gross proceeds of $1,897,905 through the issuance…

Continue Reading

MondayFeb 12, 2024 8:30 am

NetworkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Receives FDA IND Approval for Phase 2 OASIS Trial of TNX-102 SL in Acute Trauma Patients

Tonix Pharmaceuticals Holding (NASDAQ: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, today announced that it has received approval from the U.S. Food and Drug Administration (“FDA”) for the Investigational New Drug (“IND”) application for the investigator-initiated OASIS trial. The OASIS trial is a Phase 2 trial to evaluate TNX-102 SL in reducing the severity of acute stress reaction (“ASR”) and the frequency of acute stress disorder (“ASD”) and posttraumatic stress disorder (“PTSD”). The trial will enroll approximately 180 acute trauma patients following motor vehicle collisions. It is sponsored by The University of North Carolina…

Continue Reading

FridayFeb 09, 2024 3:07 pm

NetworkNewsBreaks — Immix Biopharma Inc. (NASDAQ: IMMX) Closes on $15M Public Offering

Immix Biopharma (NASDAQ: IMMX), a clinical-stage biopharmaceutical company pioneering personalized therapies for oncology and immunology, has closed on its previously announced underwritten public offering. The offering consisted of 5,535,055 shares of IMMX common stock, with each share sold at $2.71 per share. Gross proceeds from the offering to ImmixBio are projected to be an estimated $15 million, before standard deductions and expenses. According to the announcement, ImmixBio plans to use funds from the offering for its NXC-201 clinical trials as well as working capital and general corporate purposes. Titan Partners Group, a division of American Capital Partners, acted as sole…

Continue Reading

FridayFeb 09, 2024 1:49 pm

NetworkNewsBreaks – Sustain Southern California Prepares to Host This Month’s Sustainable Agriculture and Food Systems Event

Sustain Southern California (Sustain SoCal), a nonprofit organization, has announced its upcoming Innovating toward Sustainable Agriculture and Food Systems event. The conference is slated for Feb. 20, 2024, in Irvine, California, and is designed to present years of sustainability experience and gather renowned experts in the innovative agriculture space. Event speakers include A. G. Kawamura, a founding member of Orange County Produce LLC.; Jacob Raykhelson, senior manager of environmental sustainability at the Walt Disney Company; Darren Haver, director of UC ANR Research and Extension Center System; Adrian Hightower, PhD, PE, ENV-SP, sustainability and resilience manager at the Metropolitan Water District of Southern California;…

Continue Reading

FridayFeb 09, 2024 1:43 pm

NetworkNewsBreaks — Perfect Moment Ltd. (NYSE American: PMNT) Shares Pricing on Expected $8M Initial Public Offering

Perfect Moment (NYSE American: PMNT), a luxury lifestyle brand that combines fashion and technical performance for its ranges of skiwear, outerwear, swimwear and activewear, announced the pricing of its initial public offering. The offering, which is expected to close on Feb. 12, 2024, is comprised of 1,334,000 shares of common stock at $6 per share; gross proceeds of the offering are projected to reach an estimated $8 million, before deductions. The company noted that it has also granted the underwriters a 45-day option to purchase an additional 200,100 shares of common stock to cover any overallotments. Shares are expected to…

Continue Reading